EMED (Electromedical Technologies) FCF Margin %: -72.09% (As of Sep. 2024)

What is Electromedical Technologies FCF Margin %?

Electromedical Technologies EMED FCF Margin % is -72.09% as of Sep. 2024.

FCF Margin % is calculated as Free Cash Flow divided by its Revenue. Electromedical Technologies's Free Cash Flow for the three months ended in Sep. 2024 was $-0.03 Mil. Electromedical Technologies's Revenue for the three months ended in Sep. 2024 was $0.04 Mil. Therefore, Electromedical Technologies's FCF Margin % for the quarter that ended in Sep. 2024 was -72.09%.

As of today, Electromedical Technologies's current FCF Yield % is 0.00%.

The historical rank and industry rank for Electromedical Technologies's FCF Margin % or its related term are showing as below:

EMED' s FCF Margin % Range Over the Past 10 Years
Min: -14.19 Med: 0 Max: 0
Current: -14.19

EMED's FCF Margin % is not ranked
in the Medical Devices & Instruments industry.
Industry Median: -0.375 vs EMED: -14.19

Electromedical Technologies FCF Margin % Related Terms

Electromedical Technologies FCF Margin % Historical Data

* Premium members only.

The historical data trend for Electromedical Technologies's FCF Margin % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Electromedical Technologies FCF Margin % Chart

Electromedical Technologies Annual Data

Trend

Dec19

Dec20

Dec21

Dec22

Dec23

FCF Margin %

-33.86

-181.17

-131.64

-67.22

-116.16

Electromedical Technologies Quarterly Data
	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24	Jun24	Sep24
FCF Margin %	Get a 7-Day Free Trial															-85.80	-14.49	-54.48	45.80	-72.09

EMED vs DYNT, SONX, USAQ: FCF Margin % Comparison

For the Medical Devices subindustry, Electromedical Technologies's FCF Margin %, along with its competitors' market caps and FCF Margin % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Electromedical Technologies FCF Margin % vs Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, Electromedical Technologies's FCF Margin % distribution charts can be found below:

* The bar in red indicates where Electromedical Technologies's FCF Margin % falls into.

Save Embed

Electromedical Technologies FCF Margin % Calculation

FCF margin is the ratio of Free Cash Flow divided by net sales or Revenue, usually presented in percent.

Electromedical Technologies's FCF Margin for the fiscal year that ended in Dec. 2023 is calculated as

FCF Margin	=	Free Cash Flow (A: Dec. 2023 )	/	Revenue (A: Dec. 2023 )
	=	-1.567	/	1.349
	=	-116.16 %

Electromedical Technologies's FCF Margin for the quarter that ended in Sep. 2024 is calculated as

FCF Margin	=	Free Cash Flow (Q: Sep. 2024 )	/	Revenue (Q: Sep. 2024 )
	=	-0.031	/	0.043
	=	-72.09 %

Frequently Asked Questions Learn more about FCF Margin % →

What does a FCF Margin % of -72.09% mean?

Electromedical Technologies (EMED) has a FCF Margin % of -72.09% as of Sep. 2024. Free cash flow margin is the ratio of total free cash flow to net sales. View historical data on Electromedical Technologies and its competitors.

Is Electromedical Technologies' FCF Margin % too high?

Electromedical Technologies' current FCF Margin % is -72.09%.

How does Electromedical Technologies' FCF Margin % compare to DYNT and SONX?

Electromedical Technologies' FCF Margin % of -72.09% can be compared against companies in the Medical Devices & Instruments industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.

What is a good FCF Margin % for a Medical Devices & Instruments company?

A good FCF Margin % depends on the Medical Devices & Instruments industry context. However, FCF Margin % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.

What does a high FCF Margin % mean?

A high FCF Margin % can signal that a stock is expensive relative to its fundamentals. Free cash flow margin is the ratio of total free cash flow to net sales. View historical data on Electromedical Technologies and its competitors. Electromedical Technologies's current FCF Margin % is -72.09%. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.

Is Electromedical Technologies stock overvalued right now?

Electromedical Technologies (EMED) has a current FCF Margin % of -72.09%. The current FCF Margin % is -72.09%. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.

How is FCF Margin % calculated?

FCF Margin % is calculated from a company's financial statements. For Electromedical Technologies (EMED), the current FCF Margin % is -72.09% as of Sep. 2024. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Electromedical Technologies Business Description

Industry Healthcare Medical Devices & Instruments

Comparable Companies DYNT SONX USAQ AFIB BIOLQ OPGN ESMC BJDX NUMD NUWE ABT BSX SYK MDT XTER:SHL EW SZSE:300760 DXCM XAMS:PHIA STE

Address 10105 E. Via Linda, No. 103-300, Scottsdale, AZ, USA, 85258

Website https://www.electromedtech.com

Electromedical Technologies Inc is a Delaware-based bioelectronics manufacturing company. The company designs, develops, and markets FDA-cleared, non-invasive, and simple-to-use bioelectronics therapy medical devices that serve as drug-free alternatives for pain relief. The company's device provide immediate and long-lasting pain relief across the broadest range of ailments. It focuses on improving globalised wellness for people suffering from various painful conditions.